Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine

Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice

(2014) E. H. Kim et al.   JOURNAL OF VIROLOGY

Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models

(2014) Guangyu Zhao et al.   PLoS One

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines

(2014) Cuiqing Ma et al.   VACCINE

Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens

(2014) Yinghua Tang et al.   VETERINARY MICROBIOLOGY

The evolving history of influenza viruses and influenza vaccines

(2013) Claude Hannoun   Expert Review of Vaccines

An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge

(2013) Ji-Hong Ma et al.   Virology Journal

Bacillus subtilis

(2012) Hellen Amuguni et al.   Human Vaccines & Immunotherapeutics

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

(2011) K. Tamura et al.   MOLECULAR BIOLOGY AND EVOLUTION

Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults

(2011) Christine B. Turley et al.   VACCINE

Immunology of gut mucosal vaccines

(2010) Marcela F. Pasetti et al.   IMMUNOLOGICAL REVIEWS

Research and development of universal influenza vaccines

(2010) Lanying Du et al.   MICROBES AND INFECTION

Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin

(2010) H. Keipp Talbot et al.   PLoS One

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant

(2010) Guangyu Zhao et al.   VACCINE

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

(2010) Guangyu Zhao et al.   Virology Journal

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses

(2010) Guangyu Zhao et al.   Virology Journal

Influenza A viruses: why focusing on M2e-based universal vaccines

(2010) Seyyed Mahmoud Ebrahimi et al.   VIRUS GENES

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments

(2009) Michael Schotsaert et al.   Expert Review of Vaccines

Immunogenicity of self-adjuvanticity oral vaccine candidate based on use of Bacillus subtilis spore displaying Schistosoma japonicum 26 KDa GST protein

(2009) Li Li et al.   PARASITOLOGY RESEARCH

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

(2008) R WANG et al.   ANTIVIRAL RESEARCH

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

(2007) James W. Huleatt et al.   VACCINE